secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioRestorative Therapies, Inc. (BRTX)
CIK:        0001505497
Form:       8-K
Filed at:   2026-09-01T22:09:03+00:00
Accession:  0001213900-26-096337
Event type: leadership
Sentiment:  negative
Materiality: 0.75
Item codes: 4.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioRestorative appoints Mika Grasso interim CEO, Anna Skowron CFO; dismisses auditor CBIZ
--------------------------------------------------------------------------------

- Katharyn Field steps down as interim CEO/CFO, resigns from board; consulting deal with EEAK at $10k/month.
- Mika Grasso appointed interim CEO effective Aug 26, 2026; consulting deal with Currensea Capital at $10k/month.
- Anna Skowron appointed CFO effective Aug 27, 2026; consulting deal with BPC Consulting at $12k/month.
- Dismissed CBIZ as auditor, engaged Bush & Associates CPA; CBIZ report had going concern explanatory paragraph.
- No disagreements with CBIZ on accounting principles; audit committee changes: Steven Brown named chair.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1505497/000121390026096337/0001213900-26-096337-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1505497/000121390026096337/ea0304309-8k_biore.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-096337

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer